Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate
Tan Yang,1,* Ling Xu,1,* Bin Li,1 Weijie Li,1 Xiang Ma,1 Lingling Fan,2 Robert J Lee,3 Chuanrui Xu,1 Guangya Xiang1 1Department of Biopharmaceuticals, School of Pharmacy, 2Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People&a...
Guardado en:
Autores principales: | Yang T, Xu L, Li B, Li W, Ma X, Fan L, Lee RJ, Xu C, Xiang G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb1f3f853cf842fda2bbe22063f78726 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy
por: Tan R, et al.
Publicado: (2021) -
Folate-modified Annonaceous acetogenins nanosuspensions and their improved antitumor efficacy
por: Hong JY, et al.
Publicado: (2017) -
Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou XQ, et al.
Publicado: (2018) -
EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy
por: Ye Z, et al.
Publicado: (2021) -
Effect of inhibitors of endocytosis and NF-kB signal pathway on folate-conjugated nanoparticle endocytosis by rat Kupffer cells
por: Tang H, et al.
Publicado: (2017)